Nir Giladi
Nir Giladi publishes mostly in Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Parkinson's Disease and Spinal Disorders.
- World rank
- #2,089,894 of 7,710,434 ranked researchers
- Rank in Israel
- #13,930 of 38,292
- Works
- 72
- Citations
- 4.1k
- Citations per work
- 57.1
What does Nir Giladi research?
Nir Giladi's work is mostly in Medicine (57%), Neuroscience (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4157.0%
- Medicine4157.0%
- Everything else2839.2%
- Life Sciences33.8%
- Neuroscience33.8%
- 1Neurology42% of their works
- 2Psychiatry and Mental health4% of their works
- 3Cellular and Molecular Neuroscience4% of their works
- 4Physiology4% of their works
- 5Rheumatology4% of their works
- 6Pharmacology2% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Parkinson's Disease and Spinal Disorders
- Botulinum Toxin and Related Neurological Disorders
- Balance, Gait, and Falls Prevention
- Glycogen Storage Diseases and Myoclonus
- Nuclear Receptors and Signaling
- Schizophrenia research and treatment
Which keywords describe Nir Giladi's research?
The keywords of their largest research topics: Parkinson's Disease, Neurodegeneration, Dopaminergic Neurons, Neurological Disorders, a-Synuclein, Genetic Risk Factors, Deep Brain Stimulation and Epilepsy.
- Nurr1
- NR4A2
- Metabolism
- Gait Speed
- Neurotoxins
- Dropped Head Syndrome
- Subthalamic Nucleus
- Epilepsy
- a-Synuclein
- Neurological Disorders
- Neurodegeneration
- Parkinson's Disease
- Dopaminergic Neurons
- Genetic Risk Factors
- Deep Brain Stimulation
- Basal Ganglia
- Camptocormia
- Botulinum Toxin
- Fall Risk
- Glycogen
- Antipsychotic Drugs
- Neurocognitive Deficits
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Parkinson's Disease655 topics
- Neurodegeneration383 topics
- Dopaminergic Neurons342 topics
- Neurological Disorders343 topics
- Genetic Risk Factors311 topic
- a-Synuclein311 topic
- Deep Brain Stimulation272 topics
- Epilepsy232 topics
- Basal Ganglia191 topic
- Subthalamic Nucleus191 topic
- Camptocormia81 topic
- Dropped Head Syndrome81 topic
- Botulinum Toxin71 topic
- Neurotoxins71 topic
- Fall Risk41 topic
- Gait Speed41 topic
- Glycogen41 topic
- Metabolism41 topic
- Antipsychotic Drugs31 topic
- NR4A231 topic
- Neurocognitive Deficits31 topic
- Nurr131 topic
Where does Nir Giladi work?
Nir Giladi's main affiliation in the publication record is Tel Aviv University, Israel.
How many publications and citations does Nir Giladi have?
OpenAlex counts 72 works and 4,108 citations for Nir Giladi, an h-index of 16, ranking #2,089,894 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Nir Giladi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nir Giladi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.